Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP (Q24302267)

GOA release 2020-03-11

author name string

Eriko Nitta

1

0 references

Koji Izutsu

2

0 references

Yuko Yamaguchi

3

0 references

Yoichi Imai

4

0 references

Seishi Ogawa

5

0 references

Shigeru Chiba

6

0 references

Mineo Kurokawa

7

0 references

Hisamaru Hirai

Crystal structure of the BTB domain from PLZF

8

0 references

language of work or name

English

0 references

publication date

8 September 2005

0 references

published in

Oncogene

0 references

volume

24

0 references

issue

40

0 references

page(s)

6165-73

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

Blimp-1 is the murine homolog of the human transcriptional repressor PRDI-BF1

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

Efficient selection for high-expression transfectants with a novel eukaryotic vector

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208754

The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

Mll rearrangements in haematological malignancies: lessons from clinical and biological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

Prognostically useful gene-expression profiles in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

Oncogenic transcription factors in the human acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

Dimerization of MLL fusion proteins immortalizes hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

Dimerization: a versatile switch for oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021

MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208754

7 January 2021